SUFU Antibody [B21L1]

製品コード:F4640

印刷

生物学的記述

Specificity SUFU Antibody [B21L1] detects endogenous levels of total SUFU protein.
Background SUFU (Suppressor of Fused) is a core negative regulator of the Hedgehog (Hh) signaling pathway, essential for embryonic patterning and tissue homeostasis. It sequesters GLI transcription factors in the cytoplasm via its structured N-terminal domain (NTD), which features four α-helices that form a hydrophobic SYGHL-binding pocket, engaging the conserved C-terminal motif of GLI proteins. The intrinsically disordered C-terminal domain (CTD, residues 279–360) remains flexible for regulatory interactions and is flanked by a central helical region and SYGHL-binding groove that undergo significant conformational shifts upon GLI binding, stabilizing the inhibitory SUFU-GLI complex. In the absence of Hh ligand, SUFU binds full-length GLI2/3 (FL-GLI) through dual NTD-CTD interfaces, preventing GLI nuclear translocation and activator function, while facilitating PKA/GSK3β/SCF Slimb-mediated partial proteolysis of GLI3 into its repressor form (GLI3R) through cytoplasmic retention and phosphorylation scaffolding. Upon Hh stimulation, activated Smoothened (Smo) at the primary cilium recruits SUFU-GLI complexes, triggering their rapid dissociation via conformational changes in SUFU’s CTD loop, thereby relieving GLI inhibition, enabling GLI nuclear translocation and activation of target genes (Ptch1, Gli1), and inhibiting proteolysis, with GSK3β phosphorylation of SUFU fine-tuning this regulatory balance. Germline SUFU mutations cause Gorlin-like syndrome, characterized by high penetrance of medulloblastoma and basal cell nevus syndrome (BCNS), through ligand-independent GLI activation. Somatic SUFU loss drives approximately 10% of medulloblastomas and rhabdomyosarcomas via derepressed GLI signaling and enhanced tumor stemness.

使用情報

Application WB Dilution
WB
1:1000
Reactivity Human, Mouse, Rat, Monkey
Source Rabbit Monoclonal Antibody MW 54 kDa
Storage Buffer PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
Storage
(from the date of receipt)
-20°C (avoid freeze-thaw cycles), 2 years
WB
Experimental Protocol:
 
Sample preparation
1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature.
2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
5. Remove a small volume of lysate to determine the protein concentration;
6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
 
Electrophoretic separation
1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
 
Transfer membrane
1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
Recommended conditions for wet transfer: 200 mA, 120 min.
( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
 
Block
1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
2. Incubate the film in the blocking solution for 1 hour at room temperature;
3. Wash the film with TBST for 3 times, 5 minutes each time.
 
Antibody incubation
1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
2. Wash the film with TBST 3 times, 5 minutes each time;
3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
 
Antibody staining
1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

References

  • https://pubmed.ncbi.nlm.nih.gov/24311597/
  • https://pubmed.ncbi.nlm.nih.gov/20956384/

Application Data

WB

Validated by Selleck

  • F4640-wb.gif
    Lane 1: Hela, Lane 2: COS, Lane 3: NIH/3T3, Lane 4: A10